Recent abacavir use and incident cardiovascular disease in contemporary-treated people with HIV. Nadine Jaschinski , Lauren Greenberg , Bastian Neesgaard , Jose M Miró , Katharina Grabmeier-Pfistershammer , Gilles Wandeler , Colette Smith , Stéphane De Wit , Ferdinand Wit , Annegret Pelchen-Matthews , Cristina Mussini , Antonella Castagna , Christian Pradier , Antonella d'Arminio Monforte , Jörg Vehreschild , Anders Sönnerborg , Alain V Anne , Andrew Carr , Loveleen Bansi-Matharu , Jens Lundgren , Harmony Garges , Felipe Rogatto , Robert Zangerle , Huldrych F Günthard , Line D Rasmussen , Coca Nescoi , Marc Van Der Valk , Marianna Menozzi , Camilla Muccini , Amanda Mocroft , Lars Peters , Lene Ryom AIDS（2023）
摘要
Within RESPOND's contemporarily treated population, a significant association between CVD incidence and recent ABC use was confirmed and not explained by preferential ABC use in individuals at increased CVD or CKD risk.
更多 查看译文
关键词
abacavir, antiretroviral drugs, antiretroviral therapy, cardiovascular disease
AI 理解论文
溯源树
样例
